切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - SUMOylation - Valosin-containing protein (VCP) - HMG-CoA Reductases

14件产品中的 1-10

页面
每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. MLN4924
    B1036 MLN4924
     5 Citation
    Target: NAE|Ubiquitin-activating Enzyme E1|SUMOylation
    Summary: NAE抑制剂
      ≥22.18 mg/mL
      insoluble in H2O
  4. Mevastatin
    B1788 Mevastatin
    中文名: 美伐他汀
    Target: HMG-CoA Reductases
    Summary: HMG-CoA还原酶抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. NMS-873
    B2168 NMS-873
     3 Citation
    Target: Valosin-containing protein (VCP)
    Summary: VCP/p97抑制剂
      ≥17.1 mg/mL
      insoluble in H2O
  8. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  9. Simvastatin (Zocor)
    A8522 Simvastatin (Zocor)
    中文名: 辛伐他汀
    Target: HMG-CoA Reductases
    Summary: HMGCR(HMG-CoA还原酶)抑制剂
      ≥20.95 mg/mL
      insoluble in H2O
  10. Pitavastatin Calcium
    A8504 Pitavastatin Calcium
     1 Citation
    中文名: 匹伐他汀钙
    Target: HMG-CoA Reductases
    Summary: 酶HMGCR抑制剂
      ≥34.85 mg/mL
      insoluble in H2O

14件产品中的 1-10

页面
每页